CoChat
Sign Up
Cited by 13Nutrition and Health in AgingDiabetes, Cardiovascular Risks, and LipoproteinsFrailty in Older Adults

Possible sarcopenia, sarcopenic obesity phenotypes and their association with diabetes: Evidence from LASI wave-1 (2017-18)

Kaur, Inderdeep, Das, Shromona, Chandel, Shivangi, Chandel, Shivani·2025·Diabetes & Metabolic Syndrome: Clinical Research & Reviews
DOI 10.1016/j.dsx.2025.103185
Open this paper in CoChat — free account

Abstract

Aims To assess the prevalence of possible sarcopenia and sarcopenic obesity phenotypes and investigate their association with self-reported diabetes among community-dwelling individuals aged 45 or above.Methods Utilizing data from 62,899 individuals in LASI wave-1 (2017-18), the assessment of possible sarcopenia was done on two critical parameters: muscle (handgrip) strength and physical performance (gait speed), following the 2019 guidelines from the Asian working group on sarcopenia (AWGS). BMI, WC, WHR, and WHtR defined sarcopenic obesity phenotypes. Binary logistic regression analysis explored the association of possible sarcopenia and sarcopenic obesity phenotypes with self-reported diabetes.Results The prevalence of possible sarcopenia and sarcopenic obesity defined by BMI was found to be 44.4 % and 10.6 %, respectively. Individuals with possible sarcopenia exhibited a 1.18 times higher likelihood of developing self-reported diabetes (p < 0.001), while those with sarcopenic obesity by BMI had significantly elevated odds (1.94, 95 % CI 1.81-2, p < 0.001) for self-reported diabetes.Conclusions Sarcopenia and sarcopenic obesity phenotypes may increase the risk of developing diabetes as we age. Therefore, it is imperative to formulate targeted preventive and therapeutic strategies to combat sarcopenia and diabetes among the aging population.

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2025.103185

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prevalence of sarcopenia among individuals with type 2 diabetes ranges from 7% to 29%, depending on diagnostic criteria and study population, with higher rates in older adults and those with long-standing disease.

    “The prevalence of sarcopenia among individuals with T2D ranges from 7% to 29%, depending on the diagnostic criteria and study population, with higher rates observed in older adults and in patients with long-standing disease [1].”

    From Muscle loss and GLP-1R agonists use (2025) · cites this paper as [1]

Cites

Flagged first, then by citations

1 of the 79 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Bereda, 2021, Brief overview of diabete mellitus, Diabetes Manag S, 1, 21

Cited by

Sorted by citations

Related

Authors
Kaur, I., Das, S., Chandel, S., & Chandel, S.
Affiliations
University of Delhi (IN)
Corresponding author
  • Chandel, Shivangi
  • Chandel, Shivani
ORCID
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2025-02
Volume
19
Issue
2
Pages
103185
ISSN
1871-4021 (ISSN-L)
DOI
10.1016/j.dsx.2025.103185
OpenAlex
W4406275730
Semantic Scholar
41770ea237092a8a25795ad9df8ad1f5250e7307
Cited by
13
References
79
Citations by year
2026: 7 · 2025: 6
FWCI
7.29
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Diabetes & Metabolic Syndrome Clinical Research & Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Keywords
sarcopenia, sarcopenic obesity, diabetes mellitus, grip strength, walking speed, body mass index, waist-to-hip ratio, waist-to-height ratio, Asian Working Group for Sarcopenia, older adults, prevalence, diabetes risk
MeSH terms
Aged, Aged, 80 and over, Cross-Sectional Studies, Diabetes Mellitus, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Phenotype, Prognosis, Risk Factors, Body Mass Index, Prevalence, Hand Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review